Your browser doesn't support javascript.
loading
Obesity paradox in patients with reduced ejection fraction eligible for device implantation - an observational study.
Merkel, Eperke D; Behon, Anett; Masszi, Richard; Schwertner, Walter R; Kuthi, Luca; Veres, Boglárka; Osztheimer, István; Papp, Roland; Molnár, Levente; Zima, Endre; Gellér, László; Kosztin, Annamária; Merkely, Béla.
Affiliation
  • Merkel ED; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Behon A; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Masszi R; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Schwertner WR; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Kuthi L; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Veres B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Osztheimer I; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Papp R; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Molnár L; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Zima E; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Gellér L; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Kosztin A; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
ESC Heart Fail ; 2024 Jul 19.
Article in En | MEDLINE | ID: mdl-39031161
ABSTRACT

AIMS:

Patients with obesity have an overall higher cardiovascular risk, at the same time obesity could be associated with a better outcome in a certain subgroup of patients, a phenomenon known as the obesity paradox. Data are scarce in candidates for cardiac resynchronization therapy (CRT). We aimed to investigate the association between body mass index (BMI) and all-cause mortality in patients eligible for CRT.

METHODS:

Altogether 1,585 patients underwent cardiac resynchronization therapy between 2000-2020 and were categorized based on their BMI, 459 (29%) patients with normal weight (BMI < 25 kg/m2), 641 (40%) patients with overweight (BMI 25- < 30 kg/m2) and 485 (31%) with obesity (BMI ≥ 30 kg/m2). The primary endpoint was all-cause mortality, heart transplantation, and left ventricular assist device implantation. We assessed periprocedural complications and 6-month echocardiographic response.

RESULTS:

Normal-weight patients were older compared to patients with overweight or obesity (70 years vs. 69 years vs. 68 years; P 2 26% vs. BMI 25- < 30 kg/m2 37% vs. BMI ≥ 30 kg/m2 48%; P 2 71% vs. BMI 25- < 30 kg/m2 74% vs. BMI ≥ 30 kg/m2 82%; P 2 group, 61% in the BMI 25- < 30 kg/m2 group and 58% in the BMI ≥ 30 kg/m2 group (log-rank P2 25% vs. BMI 25- < 30 kg/m2 28% vs. BMI ≥ 30 kg/m2 26%; P = 0.48). Left ventricular ejection fraction improved significantly in all patient groups (BMI < 25 kg/m2 median ∆ $$ \Delta $$ -LVEF 7% vs. BMI 25- < 30 kg/m2 median ∆ $$ \Delta $$ -LVEF 7.5% vs. BMI ≥ 30 kg/m2 median ∆ $$ \Delta $$ -LVEF 6%; P < 0.0001) with a similar proportion of developing reverse remodeling (BMI < 25 kg/m2 58% vs. BMI 25- < 30 kg/m2 61% vs. BMI ≥ 30 kg/m2 57%; P = 0.48); P = 0.75).

CONCLUSIONS:

The obesity paradox was present in our HF cohort at long-term, patients underwent CRT implantation with obesity and free of comorbidities showed mortality benefit compared to normal weight patients. Patients with obesity showed similar echocardiographic response and safety outcomes compared to normal weight patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESC Heart Fail / ESC heart failure Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESC Heart Fail / ESC heart failure Year: 2024 Document type: Article Affiliation country: Country of publication: